Skip to main content
Premium Trial:

Request an Annual Quote

Alpco Names BioCat Exclusive Distributor in Germany

NEW YORK (GenomeWeb News) – BioCat said today it has signed an exclusive deal to distribute Alpco Diagnostics' products in Germany.

Salem, NH-based Alpco develops metabolism assays, including insulin ELISA kits, as well as assays for factors involved in diabetes, obesity, and cardiovascular diseases. Financial and other terms of the deal were not disclosed.

In a statement, Michael Ehret, CEO of Heidelberg, Germany-based BioCat, said that Alpco's ELISA kits have allowed his firm to build a solid customer base, and today's deal "will bring this collaboration to a new level."

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.